We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study to Assess the Safety, Tolerability and PK Response and Explore the PD Response Following 4 Weekly SC Injections of PB1046 in Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02808585
Recruitment Status : Active, not recruiting
First Posted : June 22, 2016
Last Update Posted : November 6, 2017
Information provided by (Responsible Party):
PhaseBio Pharmaceuticals Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : November 2017
  Estimated Study Completion Date : November 2017